Protein factors can regulate gene expression by binding to specifically modified DNA-associated proteins. Small molecules that selectively interfere with such interaction may be of therapeutic value. See Article p.1067 & Letter p.1119
References
Filippakopoulos, P. et al. Nature 468, 1067–1073 (2010).
Nicodeme, E. et al. Nature 468, 1119–1123 (2010).
Gershey, E. L., Vidali, G. & Allfrey, V. G. J. Biol. Chem. 243, 5018–5022 (1968).
Choudhary, C. et al. Science 325, 834–840 (2009).
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D. & Patel, D. J. Nature Struct. Mol. Biol. 14, 1025–1040 (2007).
Cole, P. A. Nature Chem. Biol. 4, 590–597 (2008).
Lemoine, M. & Younes, A. Discov. Med. 10, 462–470 (2010).
Wells, J. A. & McClendon, C. L. Nature 450, 1001–1009 (2007).
Sachchidanand et al. Chem. Biol. 13, 81–90 (2006).
Morinière, J. et al. Nature 461, 664–668 (2009).
Reynoird, N. et al. EMBO J. 29, 2943–2952 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taverna, S., Cole, P. Reader's block. Nature 468, 1050–1051 (2010). https://doi.org/10.1038/4681050a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4681050a
- Springer Nature Limited
This article is cited by
-
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
Scientific Reports (2020)